Clinical Trial for COVID-19 Vaccine

Learn about a no-cost, new SARS-CoV-2 vaccine designed to keep pace with emerging variants and further develop the current mRNA vaccine.

Computer generated image of an emerging virus

Help Fight Emerging Variants

ModernaTX Inc. is working on a new and improved mRNA vaccine to fight COVID-19 and its variants. Vaccine trials are crucial for learning more about COVID-19 and preventing serious illness. If you’re a parent or guardian to an adolescent aged 12-17 who has previously received a COVID-19 vaccine, they may qualify for the next-generation COVID-19 mRNA vaccine trial. It’s a one-time shot monitored by health professionals, and all study-related care is at no cost. Joining the trial can help to advance research and contribute to the fight against COVID-19. 

 

FILL OUT THE FORM BELOW FOR A MINOR IN YOUR CARE IF THEY MEET THE FOLLOWING CRITERIA
  • Aged between 12 to 17 years
  • Previously vaccinated against COVID-19
  • Have not tested positive for COVID-19 in the past three months
  • Have not received a COVID-19 vaccine in the past three months
  • Are not pregnant

About the study

COVID-19 causes a flu-like illness with fever/chills, cough, shortness of breath or difficulty breathing, fatigue, muscle aches, and headache. Some patients may lose sense of smell or have cognitive effects like brain fog and memory lapses. There is also a risk of developing long COVID. This next-generation vaccine provides a longer shelf-life at refrigerated temperatures, uses lower doses, and its immune response against COVID-19 is comparable to the original vaccine.

This study is a key component in fighting emerging COVID-19 variants of concern and providing protection for young, elderly, and unvaccinated individuals. Participants will be given one intramuscular injection and receive periodic follow-up for up to one year. The study will take approximately 12-13 months to complete. All examinations, laboratory work, and assessments will be made by a medical investigator at no cost. Participants may receive compensation for their time.

Why Participate?

If you are a parent or guardian for an adolescent between 12 and 17 years old, the minor in your care you may qualify for a next-generation COVID-19 mRNA vaccine study, which is now being offered at select centers throughout the US. The study is designed to reduce the risk of developing serious diseases from current variants. If the minor qualifies, they will receive:

N

No-cost Study Care

Study-related care from experienced doctors, nurses, and research staff at no cost.

N

Exams

The study will include physical exams, laboratory work, and other examination visits with a trained investigator.

N

Compensation

You might be eligible to receive compensation for your time and travel.
FILL OUT THE FORM BELOW

Chat With A Research Coordinator

Fill out the form below, and you will be advised if the minor in your care is eligible or not. If they meet the initial screening criteria, you will be contacted by someone from a research location near you. If they do not meet the minimum criteria, please still submit the form. The study criteria may change in the future, and they may become eligible later.

FILL OUT THE FORM TO CHECK THE ELIGIBILITY OF A MINOR IN YOUR CARE

© 2024 Accelerate Recruitment Accelerate Recruitment LogoPrivacy Policy | Legal Notice